The size of the global single-use bioprocessing market was worth USD 3.34 billion in 2020. It is estimated to be growing at a CAGR of 17.5% to reach USD 7.48 Billion by 2025.
Single-use bioprocessing technology is majorly utilized in the manufacturing of biopharmaceuticals. The technique is used throughout the complete biopharmaceutical production process, right from buffer and media preparation to biologics shipping. Single-use bioprocessing techniques are carried out through different products. Some of the leading products include manifold assemblies, bioprocess containers and bags, single-use bioreactors, and single-use mixers. These items lower the expenditure associated with the complex bioproduction procedures, such as cleaning, sterilization, and care of the big bioreactors.
MARKET DRIVERS:
Y-O-Y growth in demand for biopharmaceuticals and increasing R&D activities by the pharmaceutical companies are expected to accelerate the global single-use bioprocessing market growth.
According to BioPharm International, around 85% of the pre-commercial biomanufacturing includes single-use bioprocessing infrastructure. With the rising demand for pharmaceutical products worldwide, a wide range of advanced technologies comprises automation, big data, and machine learning. The rising importance for single-use products reproduced, the establishment of ongoing biomanufacturing, and healthcare industry enhancements are some other factors fuelling the global single-use bioprocessing market.
The increasing popularity of disposables in biopharmaceutical manufacturing, rising instances of chronic diseases leading to the need for biological treatment, affordable disposable products and instruments, and developing life science research infrastructure drive the global single-use growth bioprocessing systems market. Moreover, advancements in the technology of bioprocessing systems also fuelled the global single-use bioprocessing systems market. Growing numbers of joint ventures and acquisitions and quick launches of new products are the significant trends of this global single-use bioprocessing systems market.
MARKET RESTRAINTS:
However, extractability problems about disposing of plastic bags and possible environmental harm are the factors that are restricting the growth of the single-use bioprocessing market. Moreover, the waste disposal of single-use processes is also a significant challenge faced by the market.
Impact of COVID-19 on the single-use bioprocessing market:
The COVID-19 pandemic scenario has nearly affected all the industries worldwide. Single-use bioprocessing technologies command over the pre-commercial space. Most of the biopharmaceutical companies are quickly advancing vaccines in response to the pandemic crisis. There has been an increase in the bio/pharmaceutical companies' changes by reacting to the present COVID 19 pandemics. Bioprocessing and concerning supplies and support activities escalate. This comprises of quick increase over the crisis and infectious diseases and relevant research and development and manufacturing by companies and governments.
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2019 to 2025 |
|
Base Year |
2019 |
|
Forecast Period |
2020 to 2025 |
|
Segments Covered |
By Product, Application, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, Asia Pacific, Latin America, Middle East, and Africa |
This research report segmented and sub-segmented the global single-use bioprocessing market into the following categories and evaluated market size, and forecast each segment until 2025.
Single-use Bioprocessing Market – By Product:
Based on the product, the media bags and containers segment holds the largest share of the single-use bioprocessing market as of 2019, owing to the growing adoption of media bags and containers in transportation and storage.
Single-use Bioprocessing Market – By Application:
Based on the application, the filtration segment leads the market due to the growing popularity of single-use tangential flow filters, depth filters, and chromatography columns in the process development. Further, by End User, the market is classified into Research and Development Institutes and Biopharmaceutical manufacturers.
Single-use Bioprocessing Market – By Region:
Geographically, the North American market is predicted to lead the global single-use bioprocessing market, followed by Europe during the forecast period. The North American market size was estimated at USD 1 billion in 2020. Extensive biopharmaceutical manufacturing services and the high amount spent on research and development is expected to accelerate the North American Market. The United States is expected to top the North American market between 2020 to 2025. The increased expenditure spent on the healthcare sector and biologics spur market development. Furthermore, the continuous product launches and growing popularity of disposables are expected to favor the U.S. market. The Canadian market is right next to the U.S. to account second-majority of the market share. Low production price, growing awareness, and increasing incidence of chronic diseases primarily drive the Canadian market.
The European single-use bioprocessing market had accounted for a substantial share in the global market in 2020 and is estimated to showcase a CAGR of 17.6% between 2020 to 2025. Factors such as increasing R&D activities, growing disposable biopharmaceuticals, and immense manufacturing capabilities expand the market growth. The U.K single-use bioprocessing market is presently leading the EU market and is forecasted to be continuing to play a leading role during the forecast period. The German market is predicted to have a tremendous growth rate due to a surge in biopharmaceutical and biotech companies, which intensifies the system sales. According to Statista data, the number of committed biotech companies in Germany was 593 in 2015 and has risen to 679in 2018.
However, Asia-Pacific will grow at the highest CAGR because of ample investment opportunities, especially in China, India, Australia, and New Zealand. The APAC market size is expected to worth USD 1.89 billion by 2025. Growing government initiatives and the efforts of key market participants to better the healthcare infrastructure are favoring the market. The Chinese market is well-known for exporting biopharmaceutical activities such as chemical drugs. In July 2019, Sartorius opened a tech support center for biotech processing in Zhangjiang, Shanghai, China. The Indian single-use bioprocessing market to have a reasonable growth rate throughout the forecast period. The rising patient count, novel diseases, and accentuating lifestyle changes are supporting the Indian market.
The single-use bioprocessing market in the Latin American region to have a substantial growth rate during the forecast period. The local manufacturers focus on expanding their product portfolio coupled with the launch of new advanced technology products are driving the Latin American market. Brazil is expected to lead the Latin American market.
The Middle East and African regional markets witness a sluggish growth rate during the forecast period. Factors such as growing demand for cost-effective bioprocessing systems are expected to drive the market.
KEY MARKET PARTICIPANTS:
Some of the prominent companies leading single-use bioprocessing market profiled in this report are Thermo Fisher Scientific, Danaher Corporation, GE Healthcare (General Electric Company), Sartorius Stedim Biotech S.A, Merck Millipore (Merck Group), 3M Company, Eppendorf AG, Finesse Solutions, Inc., Applikon Biotechnology B.V., and Cesco Bioengineering Co., Ltd.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Media Bags and Containers
5.1.3 Filtration Assemblies
5.1.4 Single use bio-reactors
5.1.5 Disposable Mixers
5.1.6 Others
5.1.7 Y-o-Y Growth Analysis, By Product
5.1.8 Market Attractiveness Analysis, By Product
5.1.9 Market Share Analysis, By Product
5.2 Application
5.2.1 Introduction
5.2.2 Filtration
5.2.3 Storage
5.2.4 Cell Culture
5.2.5 Mixing
5.2.6 Purification
5.2.7 Y-o-Y Growth Analysis, By Application
5.2.8 Market Attractiveness Analysis, By Application
5.2.9 Market Share Analysis, By Application
5.3 End User
5.3.1 Introduction
5.3.2 Research and Development Institutes
5.3.3 Biopharmaceutical Manufacturers
5.3.4 Y-o-Y Growth Analysis, By End User
5.3.5 Market Attractiveness Analysis, By End User
5.3.6 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Application
6.1.3.4 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Application
6.1.4.4 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Application
6.1.5.4 By End User
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Thermo Fisher Scientific
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Danaher Corporation
8.3 GE Healthcare
8.4 Sartorius Stedim Biotech S.A
8.5 Merck Millipore
8.6 3M Company
8.7 Eppendorf AG
8.8 Finesse Solutions
8.9 Cytori Therapeutics
8.10 Cesco Bioengineering Co.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
